NCT01071044: Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome |
|
|
| Completed | 4 | 26 | US | Lisdexamfetamine Dimesylate, Vyvanse, Placebo "30, 50 or 70 mg", Sugar pill | Rochester Center for Behavioral Medicine, Shire | Chronic Fatigue Syndrome, Cognitive Impairments | 03/11 | 03/11 | | |
